Adarza BioSystems Overview
- Founded
-
2008
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$596K
- Investors
-
20
Adarza BioSystems General Information
Description
Developer of a biological assay platform intended to measure clinical and point-of-care samples. The company's platform offers label-free diagnostic arrayed imaging reflectometry (AIR) that is capable of simultaneous detection of hundreds of analytes in a single drop of fluid, enabling healthcare professionals to detect highly multiplexed protein with high sensitivity and specificity.
Contact Information
Website
www.adarzabio.com
Formerly Known As
Pathologics Associates
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Primary Office
- 2184 Welsch Industrial Court
- Saint Louis, MO 63146
- United States
+1 (314) 000-0000
Adarza BioSystems Timeline
Adarza BioSystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Debt - PPP | 12-Apr-2020 | $596K | 000.00 | Completed | Generating Revenue | |
| 9. Later Stage VC (Series D) | 04-Feb-2020 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 8. Later Stage VC (Series C) | 21-Dec-2017 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 7. Later Stage VC (Series B) | 24-Mar-2016 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
| 6. Grant | 21-Mar-2016 | 0000 | 00.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series A) | 04-Jun-2014 | 00.00 | 00.00 | 000.00 | Completed | Generating Revenue |
| 4. Grant | 14-May-2013 | 00.000 | 00000 | Completed | Startup | |
| 3. Grant | 01-Jan-2012 | 000.00 | 00000 | Completed | Startup | |
| 2. Early Stage VC | $100K | $100K | Completed | Startup | ||
| 1. Grant | 01-Sep-2009 | $3.04M | Completed | Startup |
Adarza BioSystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series C | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series B | 282,493 | $0.001000 | $19.17 | $19.17 | 1x | $19.17 | 3.46% | |
| Series A | 374,274 | $0.001000 | $18.2 | $18.2 | 1x | $18.2 | 4.58% |
Adarza BioSystems Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biological assay platform intended to measure clinical and point-of-care samples. The company's platform
Biotechnology
Saint Louis, MO
13
As of 2022
000.00
000000000 -
000.00
000000
nt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
0000000000 000000000
Boulder, CO
00
As of 0000
000.00
0000000000 0
000.00
000000
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
0000000000 00000000 (0000000000)
Ithaca, NY
00
As of 0000
000.00
00000000000
000.00
Add Comparison
Adarza BioSystems Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LightDeck | Venture Capital-Backed | Boulder, CO | 00 | 000.00 | 0000000000 0 | 000.00 |
| 0000000 | Venture Capital-Backed | Ithaca, NY | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 0000000000 | Corporate Backed or Acquired | Bethlehem, PA | 000 | 00.00 | 00000000000 | |
| 00000000 | Venture Capital-Backed | Toronto, Canada | 00 | 0000 | 00000000000 | 0000 |
| 000000000 | Formerly PE-Backed | Billerica, MA | 000 | 00000 | 00000000 | 00000 |
Adarza BioSystems Patents
Adarza BioSystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210285908-A1 | Consumable system for molecule detection assays | Pending | 11-Mar-2020 | 000000000 | |
| EP-3325946-A4 | Competitive small molecule detection assays using arrayed imaging reflectometry | Granted | 23-Jul-2015 | 000000000000 | 0 |
| US-20180217137-A1 | Competitive small molecule detection assays using arrayed imaging reflectometry | Abandoned | 23-Jul-2015 | 000000000000 | 0 |
| EP-3325946-A1 | Competitive small molecule detection assays using arrayed imaging reflectometry | Granted | 23-Jul-2015 | 000000000000 | |
| US-20210239689-A1 | Competitive small molecule detection assays using arrayed imaging reflectometry | Pending | 23-Jul-2015 | G01N33/54373 |
Adarza BioSystems Executive Team (11)
Adarza BioSystems Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| Benjamin Miller Ph.D | Adarza BioSystems | Co-Founder, Scientific Advisor & Board Member | 000 0000 |
| David Smoller Ph.D | Self | Board Member | 000 0000 |
| Heiner Dreismann Ph.D | Self | Board Member | 000 0000 |
| Jay Schmelter | RiverVest Venture Partners | Board Member | 000 0000 |
| Jenny Rooke Ph.D | Genoa Ventures | Board Member | 000 0000 |
Adarza BioSystems Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Adarza BioSystems Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 3x5 Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CSC UpShot Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Genoa Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Hemisphere Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Jenny Rooke | Angel (individual) | Minority | 000 0000 | 000000 0 |